• Reuters


Taiwan’s Foxconn and TSMC said on Monday they had reached deals to buy 10 million doses of BioNTech SE’s COVID-19 vaccine, putting the total cost of the highly politicized deal at around $350 million.

BioNTech’s Chinese sales agent Shanghai Fosun Pharmaceutical Group Co. said on Sunday that an agreement had been signed, though the German firm has yet to comment and no details of a delivery time-frame have been revealed yet.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.